share_log
Reuters ·  Apr 26 00:21
Alnylam Pharmaceuticals Inc : JP Morgan Cuts Target Price to $166 From $170
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment